Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

[Preprint]. 2022 Apr 12:2022.04.06.22272763. [Version 1] doi: 10.1101/2022.04.06.22272763

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.

PMC Copyright notice

Figure 3. — The table and plots show covariate-adjusted hazard ratios of COVID-19 per 10-fold increase in each Day 29 antibody marker in baseline SARS-CoV-2 seronegative per-protocol vaccine recipients (A) overall and (B, C) in subgroups. (A) Inferences for anti-spike IgG concentration, anti-receptor binding domain (RBD) IgG concentration, pseudovirus neutralization ID50 titer; (B, C) Forest plots for (B) anti-RBD IgG concentration; (C) pseudovirus neutralization ID50 titer. Baseline covariates adjusted for were baseline risk score and geographic region.